Results from a phase 2 study demonstrate that D-2570 may be an effective, well-tolerated therapy in patients with moderate to severe plaque psoriasis.

SAN ANTONIO — In the course of caring for individuals with psoriasis, clinicians should have patients complete the validated ...

The novel, oral interleukin-23 inhibitor icotrokinra bested placebo in multiple skin outcomes among adolescent patients with ...

Significant rates of depression, anxiety, and sleep disturbances in patients with psoriatic arthritis (PsA) and palmoplantar psoriasis (PPP) were identified, underscoring the need for integrated ...

Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...

Researchers reviewed hormone variation, life cycles, and their effect on quality of life specific to women with psoriasis.

Although some people with plaque psoriasis can control their symptoms by using topical treatments that are applied to the skin, some people with moderate or severe plaque psoriasis do not get enough ...

Otezla (apremilast) is an oral tablet commonly used to treat plaque psoriasis in adults and children. Plaque psoriasis is an inflammatory skin condition that causes itchy, painful patches on the skin.

The global psoriasis treatment market is projected to expand at a compound annual growth rate (CAGR) of 8.5% by 2026. Key factors fueling this growth include the rising prevalence of psoriasis, ...

Researchers have developed a patch for easier and more effective treatment of psoriasis. The method may also be used in treatment of other inflammatory skin diseases. Researchers at the University of ...